Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.8M Buy
356,002
+26,490
+8% +$984K 0.24% 44
2026
Q1
$13.2M Sell
329,512
-77,747
-19% -$3.68M 0.21% 45
2025
Q4
$18.6M Hold
407,259
0.34% 33
2025
Q3
$18M Hold
407,259
0.34% 35
2025
Q2
$19.6M Sell
407,259
-737
-0.2% -$32.1K 0.46% 28
2025
Q1
$16.2M Buy
407,996
+4,539
+1% +$191K 0.4% 33
2024
Q4
$18.5M Buy
403,457
+110,124
+38% +$4.93M 0.44% 29
2024
Q3
$13.6M Hold
293,333
0.32% 33
2024
Q2
$12.5M Buy
+293,333
New +$12.9M 0.3% 33
2018
Q2
Sell
-7,639
Closed -$262K 902
2018
Q1
$262K Hold
7,639
﹤0.01% 849
2017
Q4
$251K Hold
7,639
﹤0.01% 871
2017
Q3
$255K Buy
+7,639
New +$263K ﹤0.01% 796

Other funds holding QGEN

Barings's QGEN Position: Q2 2026 in Review

Barings increased its Qiagen (QGEN) stake by 8% in Q2 2026, buying an estimated $984K and bringing the position to 356,002 shares worth $13.8M. The position accounts for 0.24% of the portfolio, ranked #44.

Barings first reported a position in QGEN in Q3 2017 and has held it in 12 quarters since. The position peaked at $19.6M in Q2 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Barings held 356,002 shares of Qiagen worth $13.8M as of Q2 2026.
  • Barings bought 26,490 Qiagen shares in Q2 2026, an estimated $984K.
  • Qiagen made up 0.24% of Barings's portfolio in Q2 2026, its #44 holding.
  • Barings first reported a position in Qiagen in Q3 2017 and has held it in 12 quarters since.
  • Barings's Qiagen position peaked at $19.6M in Q2 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Barings's 13F filing for Q2 2026, filed 7 Aug 2026.